$GH

$166.60▲ -1.0% YTD

3 SEC 13D/G filings tracked · Last updated Oct 8, 2026

Filing History

CP $166.60▲ -1.0%Oct 8, 2026 · ThinkSabio Blog

$GH Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-…

SEC 13D/G

GH - Guardant Health, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$157.25▲ 54.56%Aug 14, 2026 · ThinkSabio Blog

$GH SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #GH Guardant Health, Inc. : $157.25 Sector: Healthcare | YTD: 🔼+ 5…

SEC 13D/G

$GH SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks Simplified

$143.62▲ 41.16%Jul 28, 2026 · ThinkSabio Blog

$GH SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #GH : $143.62 Sector: Healthcare | YTD: 🔼+ 41.16% The SEC disclose…